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Abstract
The different morphological stages of microglial activation have not yet been described in detail. We transected the
olfactory bulb of rats and examined the activation of the microglial system histologically. Six stages of bidirectional
microglial activation (A) and deactivation (R) were observed: from stage 1A to 6A, the cell body size increased, the cell
process number decreased, and the cell processes retracted and thickened, orienting toward the direction of the injury site;
until stage 6A, when all processes disappeared. In contrast, in deactivation stages 6R to 1R, the microglia returned to the
original site exhibiting a stepwise retransformation to the original morphology. Thin highly branched processes re-formed
in stage 1R, similar to those in stage 1A. This reverse transformation mirrored the forward transformation except in stages
6R to 1R: cells showed multiple nuclei which were slowly absorbed. Our findings support a morphologically defined
stepwise activation and deactivation of microglia cells.
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Introduction
The blood brain barrier creates an immunologically privileged
environment in the brain by limiting the ability of the systemic
immune system to remove infections and debris from inside of the
brain. Within the central nervous system (CNS), the function of
the extracerebral or systemic immune system is taken over by a
group of cells called microglia [1,2,3,4,5]. These cells function in
a similar way to how the immune system functions outside of the
central nervous system. Despite numerous studies on the action of
activated microglia cells [1,2,3,4,5,6,7,8,9,10], the developmental
stages from a resting inactive microglia cell to a fully activated
microglia cell have not yet been fully described histologically.
Present throughout the CNS and the spinal cord, white matter
has fewer microglia cells than grey matter. Microglia cells that are
found near blood vessels seem to lose their ramification and
become more amoeboid. The amount of microglia is not yet
clear. It has been suggested that the population of microglia cells
constitutes about 10% [11] to 20% [12,13] of all cells in the CNS,
or about 100 to 200 billion cells depending on the condition of
the system [14]. Microglia are activated by pathogens and injured
neurons, along with a host of other factors/signals that pose a
potential threat to the CNS [13]. Viral, fungal and bacterial
structures, complement factors, antibodies, chemokines, cytokines
and abnormal endogenous proteins are sensed by the microglial
receptors and are responsible for the microglial activation
[5,6,7,8]. Since microglia cells are able to sense inflammation,
and are the chemical modulators of the local environment
[5,6,7,8,9], it was thought that as soon as inflammation was
sensed the microglia became activated and transformed into
macrophages. Microglia have also been believed to be neuro-
protective [15]. This was first thought to be true only during
times of stress and injury; however, at rest the microglia appear to
spread out in a grid that allows for sensing the environment
without direct cell-cell contact. Any chemotactic change in the
environment signals the migration of microglia to sites of injury
[16,17].
Microglia cells resemble spiders: at rest, sitting on their webs,
waiting for prey; when alerted (activated), moving toward,
capturing and eating prey; afterward, returning to their resting
place (Fig. 1). The spider Xygiella x-notata lives in huge colonies
where the slightest difference in weight on the surface of their net
can be detected: ranging from 0.4 mg to 0.05 mg, in extreme cases
[8,9,10]. The spiders then migrate to the site of potential food.
Their wheel-shaped webs allow for this kind of food detection. The
spiders sit on the main strings and as they feel their prey become
entangled in the web they move toward it and devour it. Similar
behavior is seen with microglia. There is evidence that microglia
can sense and react to the stimuli [17]. It has been shown that
purines can induce chemotactic migration of cultured microglia
[17]. Microglia cells sit at the center of their ‘web’ with a foot on
each of the tension strings- in this case it can be a chemical signal,
a physical deformation, or a combination of both - in order to
sense the vibration of disturbances caused at a distance. When a
change is sensed, microglia cells retract their processes and move
in the direction of that disturbance.
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The purpose of our study was to explore the modulation and
transformation of microglia cells: from a resting stage to a fully
activated stage and returning to rest. We addressed the following
questions: how do the cells change morphologically during
activation? Is this a one-way route to macrophage? Will the cells
return to the site and re-establish the network? After injury, do the
cells orient in a direction? If so, can they be used to assess the stage
of inflammation? Are the microglia cells replaced through cell
division or do they return to the adjacent tissue after they have
phagocytosed debris? Here we show a new morphological and
orienting classification system for microglia in their activation
stages after focal injury.
Materials and Methods
Ethics statement
All experiments were carried out in accordance with the ethical
standards as described in the Society for Neuroscience guidelines
and the National Institutes of Health Guide for the Care and Use
of Laboratory Animals (NIH publications No 80-23; revised
1998). Formal approval to conduct the experiments for this study
was obtained from the Committee on the Use of Live Animals in
Teaching and Research (CULATR) at the University of Hong
Kong Faculty of Medicine (CULATR approval number 1581-07).
The minimal number of rats necessary to produce reliable
scientific data was used and all efforts were made to minimize
animal suffering.
The experimental study included adult Sprague-Dawley rats in
which the olfactory bulb was transected as standardized model for
a stimulus to activate cerebral microglia cells. For the surgery, rats
were anesthetized with a mixture of ketamine (80 mg/kg, i.p.) and
xylazine (8 mg/kg, i.p.). The olfactory bulb was exposed bilateral
by removing the overlying skull. Care was taken to cut the
olfactory bulb caudal to the bulb’s enlargement. To ensure a
complete transection, the knife was inserted through the midline of
the skull and it was moved from the midline to the lateral edge of
the olfactory tract in one continuous movement. During that
movement, contact with the underling skull was maintained. To
prevent damage to the venous sinus, the tip of the knife slightly
touched the bottom of the brain without penetration of the dura.
This procedure was modified from several previous studies in an
attempt to isolate the olfactory bulb from the other parts of the
brain [8,9,10,18,19]. The wound cleft was filled with saline using a
self-constructed hydraulic pressure injection system with a syringe
[8,9,10,18]. Care was taken to slowly inject the saline. After the
injection, the overlying scalp was re-sutured and the animals were
placed in a warm place for recovery before returning them to their
home cages. The animals were sacrificed at 2 days (n = 6 animals),
at one week (n = 6 animals) or at two weeks (n = 6 animals) after
the intervention. Four normal controls were used for baseline cell
counts. All animal procedures were carried out in accordance with
The University of Hong Kong guidelines and rules of animal care
committee in Hong Kong.
At 2, 7 and 14 days after injury, the animals were sacrificed
with sodium pentobarbital (160 mg/kg, i.p.) and perfused
transcardially with 0.9% saline, followed by 4% paraformalde-
hyde in 0.1 M phosphate buffer. Brains were dissected and
postfixed in 4% paraformaldehyde overnight at 4uC. Brains were
placed in 30% sucrose until they sank at 4uC for cryoprotection.
After embedding the blocked brains in OCT medium a freezing
cryostat was used for sectioning at 15 microns (Leica CM1900,
Leica Microsystems GmbH, Wetzlar, Germany). Sagittal sections
of the brains were placed on pre-coated slides and processed for
immunohistochemistry. Briefly, the sections were first pre-blocked
in a solution of 0.3% triton and 10% goat serum in 0.01 M
phosphate buffer solution at room temperature for one hour, and
then the primary antibody solution overnight at 4uC before
secondary labeling with the corresponding fluorescent-labeled
antibody (Invitrogen, Life Technologies, Carlsbad, CA, USA) was
carried out at room temperature for two hours. Each step was
preceded by three washes in phosphate buffer solution for
5 minutes each. Antibodies and dilutions used include ionized
calcium binding adaptor molecule 1 (Iba-1) rabbit anti-Iba-1
polyclonal antibody (1:500) (Wako Pure Chemical Industries,
Osaka, Japan) for microglia, mouse anti-ED1 (Serotec, 1:500) for
macrophages, rat-anti-BrdU (Abcam, 1:1000) for cell prolifer-
ationand Alexa-conjugated, goat anti-rabbit 568 IgG antibody
and goat anti-mouse 488 (Invitrogen, Life Technologies,
Carlsbad, CA, USA). The slides were then cover slipped with
Dako fluorescent mounting medium with DAPI. All images were
taken under a 206 or 406 objective with a Carl Zeiss Fluor
microscope (Carl Zeiss Inc. Oberkochen, Germany) fitted with a
spot camera. All illumination levels were fixed during image
acquisition. The BrdU immunohistochemistry required denatur-
ation of the DNA and sometimes tissue penetration enhance-
ment, with HCl (2 N HCl 37uC 30 minutes or at room
temperature 1 hour; 1 N HCl) or DNAase treatment and citrate
buffer boiling (0.01 M pH6.0 citrate buffer, 95uC 30 min)/
enzyme digestion (0.05% trypsin 37uC 10 min, then room
temperature 10 min), respectively. We have found that a higher
concentrated HCl treatment (4 N HCl room temperature
20 min) was sufficient to stain all cells with BrdU without the
need of citrate buffer boiling or enzyme digestion, which may
take some sections off the slides. The Iba-1 protein was resistant
to the HCL treatment and enabled co labeling without the need
to removal of cover slips and a second immunohistochemistry
step for Iba-1. Imaging of the z-axis was taken under a 636
Figure 1. Drawing of a spider web at each stage of the spider
behavior. (A): The spider is in the middle of the web waiting for prey
to hit the web; it will sense the vibration. (B): The spider senses the fly
hitting the web and begins to withdraw its legs and move in the
direction of the vibration. The spider is showing directional orientation
toward the fly. (C): The spider has left the center of the web and is
moving along the primary tension member of the web in the direction
of the fly. (D): The spider comes in contact with the fly, seizes the fly,
wraps it or eats it. (E): When the fly is consumed the spider starts the
return to the center of the web. Again, the orientation of the spider is
away from the original disturbance and toward the center of the web.
(F): The spider, back at the center of the web, has re-extended its legs to
the primary tension members of the web waiting until for another
disturbance, or a new meal. The direction of the action is driven by a
vibration disturbance that is sensed in the legs of the spider. Microglia
appear to use their processes as spider legs and move to the injured
site.
doi:10.1371/journal.pone.0030763.g001
Spider Effect-Staging of Microglia
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objective with a Zeiss LSM 510 META multiphoton microscope
to enable localization of labels and cell walls.
The acquired images were used for categorization and
quantification. All cell counting and assessment was performed
in a double masked manner. First, each of the acquired images was
relabeled with a random code and then the images were passed to
a naive member of the research team to fix the 6 counting areas on
the images. Then the images were passed to another individual to
categorize and count the quantity of each category. Microglia cells
were counted in six square areas of 1506150 mm2 per slide. The
first square was placed at the edge of the injury site and the two
subsequent squares had an inter-square distance of 50 mm. Two
series of three sampling areas were chosen per photo (Fig. 2 A).
Cells were to counted if they fell inside the sampling squares; cells
that fell on the top or left sides of the sampling squares were not
counted, while cells falling on the bottom and right sides of the
sampling square were counted. Since the surgery transected the
entire olfactory bulb, it created a distal portion and a proximal
portion of the bulb. Distal refers to the section furthest from the
brain in the rostral direction while proximal refers to the area
closest to the brain. For this study we use the proximal portion of
the transected olfactory bulb. This was to avoid the variation of
reduced blood flow to the distal portion of the bulb.
At each time point of follow-up (2, 7 and 14 days after injury),
we assessed the morphology and orientation of the activated
microglial cells at each sampling area in a distance of zero mm
(area I), 200 mm (area II) and 400 mm (area III) from the injury site
(Fig. 2). In the morphological assessment, we first examined the
stage of microglia activation according to the cell morphology. It
was based on the criteria of cell body size and shape, number of
cell processes, length of each process, orientation of the cell
processes, number of branches and length of the branches. We
then assigned a type number of ‘‘1’’ to ‘‘6’’ where ‘‘6’’ was a fully
activated macrophage. The cell bodies were measured to
determine the variation between the cell types. The number of
microglia cells for each category was converted to density (cells per
mm2) to normalize the counts. This was then converted to percent
of the total for each sampling area and time point. A subset of
images was taken for analysis to localize the nuclei within the cell
walls for DAPI, iba-1 and ED-1 staining. A second set of images
was taken with BrdU labeled sections to assess cell proliferation.
For the assessment of the orientation of the microglial cells, we
made a determination based on the orientation (direction) of the
majority of the cell processes by assigning the direction based on
the orientation of the side processes in relation to the injury. There
was prior evidence that the microglial processes direct towards the
injury site [8,9,10,18]. If the majority of the cell processes
extended in the direction of the injury then the cells were labeled
advancing (A) microglia while the cells with the majority of their
processes oriented in the opposite direction to the injury site were
termed returning (R). Cells with undetermined orientation were
labeled ‘‘undetermined’’ or ‘‘U’’.
Results
Characteristics of ‘‘advancing’’ activated microglia
Table 1 shows a summary of all of the morphological features
that distinguished all of the stages of activation of microglia. In
stage 1A, the first stage of activation, the microglia cells had a
small soma, with widely spread ramified processes and which
showed no directionality (Fig. 3 A, B). In stage 2A, the soma
increased in size to approximately 1.5 to 2 times the diameter of a
stage 1A cell. The cell processes, which were still ramified,
retreated on the side away from the injury; and the remaining
branches, closest to the cell soma, began to thicken (Fig. 3 C, D)
giving the appearance that the cell was orienting toward the injury
site. In stage 3A, the cell soma diameter had enlarged to 2 to 3
times the soma diameter at stage 1A and most cell processes had
retracted and thickened (Fig. 3 E, F). There were usually two or
more thick processes and several thin ones oriented in the
direction of the injury. The long thin branches were replaced by
short thick branches as they retracted. The processes had
disappeared on the side of the cell away from the injury. In stage
4A, the soma diameter was 3 to 4 times larger than that in stage
1A; all long thin processes had completely retracted and only the
thick branches remained (Fig. 3 G, H). Usually there was one
prominent process oriented in the direction of the injury site with
several smaller processes at a 90u angle to the injury site. These
processes usually were shorter than 25 percent of the soma size. In
stage 5A, the soma diameter was enlarged to 5 times the cell size in
stage 1A; the prominent thick process had thinned and appeared
to be oriented in the direction of the injury site and were as long as
75 mm (Fig. 3 I, J). The emergence of the ED1 signal also
appeared and continued through stage 5R. Stage 6A was
characterized as a fully activated microglia cell with a macrophage
character (Fig. 3 K, L). The long process was very short: 50% of
the soma diameter or completely gone. The cell was spheroid or
spherical in shape and the soma had grown in size to
1462 microns. The cell was at the edge of the injury site, or
within 50 microns of the edge of the damaged tissue. In Graph I,
II and III, the advancing microglia cells are shown in red in the
negative region of the graph show that they are migrating toward
the injury site (Fig. 4). The regressing microglia cells are shown in
green and purple described in detail later. The full range of
activation to complete deactivation is shown in tracings of selected
prototypic cells from the tissue for each stage (Fig. 5).
Characteristics of ‘‘returning’’ activated microglia
Stage 6R was characterized as a multinucleated cell because of
cell debris phagocytosis. Most cells had a prominent ED1 signal
indicating they had transformed to macrophages but continued to
retain the Iba-1 signal. The location of these cells was at the injury
interface; however, there were a few exceptions. A small
population of the cells with prominent ED1 staining appeared
adjacent to dead or dying cells in the olfactory bulb. As the cells
acquired more than three nuclei, the macrophages appeared to
change direction and started to reorient away from the injury site.
Stage 5R cells had more than three nuclei and extended a thin
process away from the injury site. Some of these cells continued to
retain the ED1 signal; however, it appeared that the signal was
Figure 2. Drawing of the olfactory bulb (A) and the location of the
injury and the sampling area. (B): Photomicrograph of the sagittal
section of olfactory bulb. The sample grid used for every animal
includes both the yellow and red areas and were further broken down
into Locations I, II, and III. This was to show the movement and
depletion of the microglia from these areas and their subsequent
return. Sample grid: 150 mm.
doi:10.1371/journal.pone.0030763.g002
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quickly lost. In stage 4R, at some distance to the injury site, the cell
extended 1 to 3 thick processes oriented away from the injury site.
All evidence of ED1 labeling was absent while Iba-1 labeling
remained. In stage 3R the microglia extended 4 to 7 large short
processes oriented away from the injury site. There were also one
to two thin, short processes that were extended in the direction of
the injury site. Many cells still contained multiple nuclei. In stage
2R, the processes became thinner and 4 to 5 times longer than the
soma. Though most of the processes were oriented away from the
injury site there were one or two oriented in the direction of the
injury site. Finally, in stage 1R the cell had returned to the
inactivated state and extended the processes in all directions
(Fig. 6). Stages 1A and 1R morphologically appeared to be the
same.
Changes in density
Overall microglial activation followed the induced injury to the
olfactory bulb (Fig. 7). The level of activation was evident at the
second day after the injury (Fig. 7A) with spherical cells clustered
close to the injury site. The Iba-1 staining showed fully activated
macrophages next to the injury site in stages 4A to 6A, while the
cells located distant to the injury site were activated and showed an
orientation in direction to the injury site. By day 7, the level of
activation decreased with the majority of cells in stages 6R to 4R
(Fig. 7B). At 14 days after the injury, some cells in stage 6R
remained at the edge of the injury site. The orientation of the cells
had changed, pointing in the direction away from the injury site
for stages 5R to 1R. The cells of stage 1R were located in the
region distant to the injury site.
The mean number of microglia cell bodies in the olfactory bulb
in the untreated controls was 147610 cells/mm2. Stratified into
the different stages, the mean density of microglia cells for each
stage 1, 2, 3, 4, 5 and 6 was 8265, 2062, 1862, 961, 861, and
761 cells/mm2 respectively. In the study group, from the time
point at 2 days after injury to the time point of 14 days after injury,
we overall detected a progressive depletion of microglia cells in the
sampling regions II and III; while, at the same time, sampling
region I showed a significant increase in the density of microglia
cells. At the second day after injury, at the injury interface (area I),
the microglia cell density for the saline injected animal were 0, 0,
1861, 8864, 4063, 303614, totaling 4516105 microglia cell
bodies/mm2. This represented a three times increase in the density
of microglia/macrophages from normal tissue (Fig. 8). These
numbers decreased towards day 7 after injury, and then re-
increased at 14 day after injury (Fig. 8).
Stratified by the stages of the cells, the histological slides
obtained at 2 days after injury showed closest to the injury site
mostly cells in stages 4A to 6A, while cells in stages 1A, 2A and 3A
were mostly absent (Fig. 4). By day 7, the slides showed
predominantly microglia cells in stages of 6R, 5R, 4R to 3R
(Fig. 4). By day 14, cells in stages 6R through stage 2R were
present. A multivariate analysis, with the time point as a
dependent parameter, and cell density of the 6 stages and location
(area I to III) as independent parameters, revealed that the relative
cell density of stage 4 (P = 0.01) and stage 6 (P = 0.002) decreased
significantly with increasing time points. After adjustment for
location, the relative density of cells in stage 4 and stage 6
decreased significantly with advancing time.
Applying BrdU at the time of olfactory bulb transection
revealed that at 2 days after the injury 37% of the microglial
cells to be BrdU positive. At 7 days after injury that figure was
reduced to 3.5%, when BrdU was added at day 6. There were
some BrdU-positive cells that returned to the original stage 1
morphology.
Distance from injury site
The distance from the injury site affected the predominant
morphology or stage of the microglial cells. There was a U-shaped
distribution of the density of the microglia cells stratified by the
stages. The highest density was found next to the injury site and at
the location of 200 mm distant to the injury (location II). At day 2,
at 200 microns (location II) from the injury site, only 45% of the
microglia cells were present; and at 400 microns (location III) that
number increased to 77% of the injury site. In location II, stages
1A through 6A of microglia were present and were oriented in the
direction of the injury site (Fig. 9). A multivariate analysis, with the
sample area (area I–III) as a dependent variable and the cell
density of stages 1–6 and time as independent variables, showed an
association between a higher concentration of cells of stage 1
(P = 0.06) with increasing area number (i.e., more cells of stage 1 in
area III); and an inverse association between the cell density of
stage 3 (P = 0.008), stage 4 (P = 0.005) and stage 6 (P,0.001) with
Table 1. List of characteristics of each stage of microglial activation and de-activation.
Cell Stage Soma Size (mm) Process Number Process Diameter (mm) Branches Number Process Length/Soma Diameter
1A 2.5–5.3 4+ ,1 Compound Long .106
2A 5.0–6.8 3–4 1–2 Compound Short .46
3A 6.5–10.0 4+ 2.5–3.6 Short 1–36
4A 8.3–10.7 2–4 2.5–5 Short 1–26
5A 10.2–15.2 1–2 ,1.5 None .26
6A 12.1–16.6 1-none ,1.5 None ,16
6R 12.0–18.4 1-none ,1.5 None ,16
5R 11.4–15.2 1–2 1–2.5 None 16
4R 8.3–11.5 2–4 2.5–5 Short 1–26
3R 6.5–11.3 4+ 2.5–3.6 Short 1–36
2R 5.0–6.8 3–4 1–2 Compound short .46
1R 2.5–5.3 4+ ,1 Compound Long .106
The cell stage was defined by soma size, process number and process diameter, number of branches and process length in relation to the soma diameter. The data for
the table was the result of measuring between 150–200 cells per stage.
doi:10.1371/journal.pone.0030763.t001
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the area number, i.e. densities of cells in stages 3, 4, and 6 were
higher in area I compared with area III.
Orientation of processes
The mean number of processes for each of the time points and
location were: Area I; Day 2, 7, 14: 0.5, 1.0, 1.4 processes per cell.
The orientation of these processes was in 68% of the cells toward
the injury site, and in 31% of the cells away from the cut. By day
14, the processes of 47% of the cells were orientated toward, and
the processes of 52% of the cells were orientated away from the
cut. For Area II, the processes of 68% of the cells were orientated
toward the transection site, and the processes of 35% of the cells
were orientated away from the injury site. By day 14, the processes
of 52% of cells were orientated away from the injury site, and the
processes of 47% of the cells were orientated toward the
transection site. The mean number of processes per cell in Area
II was 1.7, 1.6, and 1.9 for 2, 7 and 14 days after the injury,
respectively (Fig. 10). In Area III, the mean number of processes
per cell was 3.4, 2.1 and 1.9 at days 2, 7, and 14 respectively
(Fig. 10). In area I, the number of processes per cell was relatively
low as compared with areas II and III, and it increased
significantly (P = 0.009) from day 2 to day 14 (Fig. 10)
Discussion
Morphological classification of activated microglia cells
Using the model of standard injury to the olfactory bulb, we
classified microglia cells into 6 morphological stages and further
added the designation of ‘A’ for advancing and ‘R’ for returning.
The third designation was an ‘U’ for undetermined when the
orientation of the cell could not clearly be detected. Cells
designated with ‘‘U’’ were mostly seen in normal controls. The
classification began with stage 1A with a small soma and widely
spread ramified processes and proceeded to stage 6A of a fully
activated microglia cell with a large, round soma and few thin, if
any, processes emerging from the soma. With increasing time after
injury, the classification reversed from stage 6R to stage 1R where
the highly ramified microglia cells were again equidistant from its
neighbors. Stages 6A and 6B were differentiated by the presence of
phagocytosis and multinuclear cells in stage 6R. An additional
possibility to explain the presence of multinucleated cells in stage 6
was that some microglia cells fused with each other. In a study by
Petersen and colleagues, phagocytosed nuclei were transferred
between microglial cells [20].
Figure 3. Photographs of microglia cells in the olfactory bulb 2
days after a standardized transection of the olfactory bulb
sectioned and stained with Iba-1. These photomicrographs are
showing the cells advancing. (A and B): Stage 1A, a microglia cell has
processes that are ramified and spread out, with a small soma. (C–D):
Stage 2A, the soma has increased in size to approximately 1.5–2 times
the soma diameter of a stage 1A cell. The cell processes have started to
retreat and the branches next to the cell soma are thickened. (E–F):
Stage 3A, the cell soma diameter is enlarged to 2–3 times the soma
diameter of stage 1A. All cell processes have retracted and thickened.
(G–H): Stage 4A, the soma diameter is 3–4 times larger than the stage 1
soma; all thin cell processes have completely retracted and only the
thick cell branches remain. (I–J): Stage 5A, soma diameter is 5 times
larger than the soma diameter in stage 1; the thick process is replaced
by a thin process oriented in the direction of the cell movement. All
branches are gone. (K–L): Stage 6A shows the transformation from
microglia to macrophage. The microglia cell has a large round
morphology with a large soma, with one short or no processes. (Scale
bar: 10 mm).
doi:10.1371/journal.pone.0030763.g003
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Figure 4. Relative microglial cell density in regions at zero mm (I), 200 mm (II) and 400 mm (III) from the injury site at 2, 7 and 14 days
after experimental transection of the olfactory bulb, stratified into 6 stages according to the morphology of resting versus
activated cells.
doi:10.1371/journal.pone.0030763.g004
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Bidirectional orientation
Using histological criteria, activated microglia were differenti-
ated along with the recognition that the process was bidirectional
with 6 progressing stages, and by 7 days post injury, 6 regressing
stages. The turning point in the orientation of the microglia cells
from progressing to regressing occurred at approximately 3 days
after the experimental injury.
In the progressing stages, the microglial cells had a clear
directionality; the cells were morphologically oriented in the
direction of the injury site. The processes appeared to be retracted
on the side opposite the injury site, but remained extended on the
side toward the direction of the injury site. Immunohistochemistry
showed that at stage 5A the cells were ED1 positive along with
Iba-1. As the cells became more densely concentrated close to the
site of injury, they became less ramified and usually had only one
process just prior to entering the area of damage. The stages 6A or
6R microglia/macrophage also had an ED1 signal along with Iba-
1. It appeared as if these were the cells of stage 6R getting ready to
phagocytose dead or dying cells along with debris. After
phagocytosis of a sufficient amount of debris, the activated
microglial cells appeared to change orientation away from the
injury site. It has remained unknown, how much debris a
transformed macrophage or microglia of stage 6R was able to
phagocytose.
In the regressing stages, microglial cells of stage 5R had
processes oriented away from the injury site, deemed as retreating,
and showed clearly visible multiple nuclei. To prevent an artifact,
we confirmed the multinuclear status of these cells by using thin
histological sections to avoid an overlapping of cells. To ensure
that the nuclei were located only in one cell, we used confocal
imaging in a second step and examined a Z-Stack of images using
the Iba-1 signal to delineate the cell walls [21]. As shown in
Figure 11, the confocal images revealed a clear demarcation of the
cellular boundaries, but could not rule out the possibility that the
nuclei were being passed from one cell to another. Between the
microglial cell stages 3R and 2R, the microglia cells lost the
additional nuclei so that from stage onwards, all the cells were
mononuclear. The loss of the multinuclear status was possibly due
Figure 6. Photographs of microglia cells in the olfactory bulb 7
days after a standardized transection of the olfactory bulb
sectioned and stained with IBA-1 (green). (A): Stage 2R, the soma
decreased in size to about 1.5–2 times the soma diameter of a stage 1A
cell; the cell processes lengthened and the cell lost its directional
orientation. Branches were clearly prominent on the processes. (B):
Stage 1R, the microglia cell had a small soma with processes that were
ramified and spread. The cell was back to its original location and
separated from the other neighboring microglia (Scale bars: 10 mm).
doi:10.1371/journal.pone.0030763.g006
Figure 7. Photomicrographs of sagittal sections of the
olfactory bulb with the experimental incision injury site to
the right. (A): Day 2 post injury. Note the accumulation of small round
cells at the injury site (at the right edge of photo); the orientation of the
cell was in direction of the injury site. (B): Day 7 post injury. The small
round cell bodies partially disappeared and the cell orientation was
away from the injury site. The cells appeared to be returning to the
tissue. (C): Day 14 post injury. There were only a few areas that still had
high concentrations of round microglia cell bodies/macrophages; the
cells were oriented away from the injury site and some highly branched
cells were present distant to the injury site. The green was Iba-1 with an
Alexa dye.
doi:10.1371/journal.pone.0030763.g007
Figure 5. The drawing are tracings of the resting activated
microglia starting in resting stage 1A, continue to an activated
stage 6A (macrophage stage), transform to stage 6R (multinu-
clear cells), and then return to a resting stage 1R. The blue
arrows indicate the increase in activation and the green arrow indicate
the transition from activated to returning. This demarcation appears to
be the point that the macrophages consume other cells and debris and
are digesting or carrying it away from the event horizon. Note that the
cells of stage 6R to stage 3R appear larger than the cells of other stages.
This is possibly due to the increased number of nuclei that they have
consumed. Some of these nuclei and cell debris appeared to have been
transferred to other macrophages.
doi:10.1371/journal.pone.0030763.g005
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Figure 8. Microglial cell density (cells/mm2) at 2, 7 and 14 days after experimental transection of the olfactory bulb in regions at
zero mm, 200 mm and 400 mm from the injury site.
doi:10.1371/journal.pone.0030763.g008
Figure 9. Graph showing the distribution of microglial cell processes oriented toward (green bars, UP) or away (purple bars, Down)
from an experimental transection site of the olfactory bulb the cut at 2, 7, and 14 days after the injury. The blue bar is the net direction
of the processes.
doi:10.1371/journal.pone.0030763.g009
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to the breakdown of the debris, or resulted from a cell apoptosis.
Since we did not detect any tunnel positive and Iba-1 positive
staining at later time points, one may infer that the microglia may
not have died but may have digested the phagocytosed additional
nuclei. We detected some BrdU positive cells that appeared to
have taken their original morphology of stage 1. As the microglia
regressed to stages 2R and 1R, they lost the orientation bias and
re-extended their processes, becoming indistinguishable from the
stage 1A microglia. The ability of the previously activated
microglia cells to regress to their original shape and location
suggest that they might have memory, which has been discussed
previously [22].
Distance from injury site
Through the sample grid which extended to 550 mm from the
injury site we detected a distance-dependent transformation of the
microglia. In the furthest sampling area (area III) at the second day
after injury, the predominant cell stage was 1A to 3A (Fig. 4), while
there was a paucity of cells in stage 5A and 6A. In contrast, in the
area closest to the injury, the majority of the microglial cells were
in stage 5 and 6 (Fig. 4). Later at seven days after the injury in area
III distant to the site of injury, the density of cells of stage 6R had
markedly increased. It indicated that the transformation of cells
from stage 1 to stage 5 and 6 had taken place in a distance
dependent, and therefore presumably concentration dependent,
manner. It would agree with the studies on ATP/ADP dependent
signals for homing of microglial cells to the site of injury [21].
Figure 10. Graph showing the mean number of processes per microglial cell at zero mm (area I), 200 mm (area II) and 400 mm (area
III) from the injury site at 2, 7 and 14 days after experimental transection of the olfactory bulb. Control animal had an average of 5.8
processes per cell. The bars show the standard deviation.
doi:10.1371/journal.pone.0030763.g010
Figure 11. Multiphoton Z-Stack images of microglia cells
immunohistochemically stained by Iba-1 to show the cell
bodies and cell processes. The panels show a Z-Stack of images
while the panels to the right and top demonstrate the level of the
image in the stack. (A): partially activated microglia with a few activated
cells. The cross hairs show the location of the cell and the upper and
right panels show the depth of the cell. (B): activated microglial cells as
by increased size and more circular shape size. (C): fully activated
microglia with several microglia cells in stage 5R. Note: the cells cover
the full thickness of the histological slide and although some cells are
located close to each other, they can clearly delineated from each other
by the Iba-1 label in the cell walls. Scale bar: 10 mm.
doi:10.1371/journal.pone.0030763.g011
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Concentration of activated microglial cells of stage 6
Comparing the three study groups with each other revealed that
at the second day after the intervention, the concentration of stage
6 cells increased significantly to 69% of the total microglia/
macrophage population at 2 days after the injury, and decreased at
1 and 2 weeks after baseline to 20% and 24% of the total
microglia/macrophage population. By the second week post
injury, 30% of the microglia cells were at stage 3R. This appeared
to be a wave of regressing and potentially returning cells to stage
1R. Further time points would have been necessary to follow the
cells back to a completely normal control level. The response was
proportional to the distance from the injury site with more and
higher activated cells in the areas closer to the injury. It may have
been due to the inflammatory signals concentration decreasing
with increasing distance to the site of injury.
Multinuclear cells
The primary distinguishing feature between microglia cells of
stage 6A and stage 6R was the presence of multiple nuclei. We
considered the presence of more than 2 nuclei as a sign to
distinguish them from dividing microglia. The second distinguish-
ing feature was the time frame. At 2 days after injury, we detected
few cells with 2 nuclei which were BrdU positive. The addition of
BrdU was made at the day of the cut in one group, and in a second
group at day 6. The two day group showed a marked increase of
BrdU signaling early, however at a later time point (day 14) this
signal disappeared completely. Another possibility that may be
considered is that the multinucleated cells could have been a result
of microglia cells fusing with each other. This would create a
multinucleated cell; and the clustering seen by others [21] could be
a precursor stage for the eventual fusing of the cells. This also may
be a way to clean up the area without the debris and without
inflammation usually seen outside of the CNS.
Spider effect
Based on the findings described above, one may consider
microglial cells to behave like spiders sitting in the middle of their
web. When a spider detects vibration on one of the primary
tension components of the web, it moves its legs to the two
adjacent strings to localize the vibration. Then the spider retracts
its legs from the other members and moves in the direction of the
vibration. However to suggest that the legs and the feet of the
spider are stationary the entire time would be an oversimplifica-
tion. They are palpating the web and constantly readjusting. In
addition, the farther away the spider is from a source of movement
in the web, the weaker the signal. The microglial cells examined in
our study may have behaved in a similar manner as spiders do.
Based on the predominant morphology of the microglial cells
stratified into the 6 stages of activation, the time of follow-up, and
the distance to the site of experimental injury performed in our
study, it appeared that the microglia retracted their processes after
sensing and localizing the damage signal and then moved in the
direction of the strongest signal, thus depleting the local area of
microglia cells. As the microglia moved to the injury site, they
transformed morphologically from stage 1A to stage 6A. In
addition, it appeared there that also other cells proliferated and
infiltrated the region. The percentage of cells that were positive for
both Iba-1and BrdU was 37% of the total microglial population
when the BrdU was applied at the time of the transection. This
figure was higher than the figure of 25% as found by Wohl and
colleagues [23]. When the crisis was over and the damage was
repaired, the microglia again transformed morphologically,
reversing direction, from stage 6R to 1R, toward their original
location, extending their processes and moving to adjust
themselves to be located equidistantly to each other. In a similar
manner, spiders return to the middle of their web extending their
legs back to several of the tension components of the web in an
equidistant way and waiting for the next disturbance.
Potential limitations of our study should be mentioned. First, as
any experimental study our investigation cannot be taken as prove
for a real clinical situation. Second, our study used fixed tissue,
which was examined immunohistochemically. Therefore, in
contrast to an in vivo examination, it was not possible to follow
individual microglial cells in their development from a resting
‘‘observing’’ stage (stage ‘‘1A’’) with an equidistant distribution of
cells in the tissue before the experimental injury was set to an
activated stage (stage ‘‘6A’’) of microglial cells moving to the site of
injury and phagocytizing tissue debris, before returning to their
original location and function (stage ‘‘1R’’). By comparing,
however, the snapshots of the histologic images taken at 2 days,
7 days and 14 days after the experimental injury, the assumption
of the development of activation and de-activation through stages
‘‘1A’’ to ‘‘6A’’ and from ‘‘6R’’ back to ‘‘1R’’ appeared deducible.
Third, the measurements in our study were based on the staining
of the microglial cells. Although the immunohistochemical staining
of microglial cells by Iba-1 has been described to be relatively
specific and sensitive for microglial cells, there is the possibility that
some microglial cells were not stained and that other cells were
stained and falsely counted as microglial cells. Fourth, we used the
location and direction of the cell processes to assume the direction
of the movement of the microglial cells. In vivo, however, the cell
body including the processes are three-dimensionally arranged so
that the appearance of the microglial cells in the mostly two-
dimensional histological slides can only be taken as a surrogate for
the three-dimensional structure of the cells and the direction into
which their processes point to. In addition, the telltale signs of
direction sensitivity and the orientation of the microglial cells
resemble that of migrating neurons seen in early development; also
in the rostral migratory stream of the olfactory bulb. The data of
our study, therefore, suggest, however, cannot definitely prove,
that the microglial cells move from their resting location in the
vicinity of the site of injury to the cutting edge of the injury in their
activated stage and then back to the original location in their then
again resting stage. Interestingly, however, our findings support a
recent investigation by Ohsawa and Kohsaka who showed that
microglia processes orientate in the direction of an acute injury
due to a release of ATP (adenosine triphosphate) [24]. Fifth, there
were several different labels available for use to differentiate
microglia at the various different stages of activation. There were
reports in the literature that different stages of activated microglial
cells can be differentiated by specific cell surface markers. For
example, lectin staining has been used to detect microglia of
multiple species [25]. The fluroscence-lectin provided staining of
the microglia without the need for a second antibody. The
successful application of lectin (especially lectin from Griffonia
simplicifolia for rat microglia) staining on microglia can be used for
staging of the microglial activation in vivo as well. However, we
found that Iba-1 was similar to the lectin staining but did not stain
the vasculature. We also used ED1 because this allowed for the
staging of activated macrophages. When the two were co-localized
we found that the combination of Iba-1 and ED1 was a better
choice to stage the microglia. When both ED1 and Iba-1 were
seen, the microglia cells were at stage 5R and the ED1 signal
remained with the microglia until stage 5R. When stage 4R was
reached, the ED1 signal was lost.
In an experimental study including the standardized transection
of the olfactory bulb, we developed a classification system for
activated microglial cells. By assessing the shape of the microglia
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cells and reading the direction of the microglia migration, that
classification system can be used to assess the effectiveness,
duration, and distribution of inflammation as well as the direction,
extent of the injury site and the time lapse after injury has
occurred. The staging of the microglial activation and eventual
deactivation may lead to a better understanding of some types of
inflammatory of the CNS, including the question of why the
microglia will take on a certain type of morphology in one disease
and a different one in another disease. The classification system
may serve as a physical biomarker for future therapies and staging
of diseases noninvasively.
Since the microglial morphology changes in response to the
environment we may be able to use microglia as a way to measure
the stage of a disease. This system also raises additional questions
as to whether the multinucleated transition of the microglia cells is
due to cell fusion of microglia that starts with clustering. This may
send a signal that the area is clear, to initiate the return to their
original position. There is one additional possibility: that as the
cells move to the area of injury creating an area that is depleted of
microglial coverage, this could send the neuronal tissue into a
mode of decreased activity, or even shock. When the microglia
return and are able to re-establish the normal grid it would allow
the neurons to return to a normal level of activity. The population
change at each area has a u shaped population density. Though
this is does not appear significant it may represent a need to extend
anti-inflammatories longer than the typical 7 days in a clinical
setting. This second wave of cells are not stage 5A/R or 6A/R
cells however they represent a possible longer term autocrine
signaling that may extend the activation period beyond what was
previously thought.
The results of our study agree with previous investigations in
that we found signs that microglia cells were bidirectional; they did
not only cluster and migrate toward an injury site, which resulted
in a higher density, but they also appeared to migrate back to their
origin, although this was the first it had been seen in vivo. Our study
also agrees with the study by Carbonell and colleagues on
migration of microglia in slice culture [22]. This, along with our
data, suggests that the migrating microglia will migrate toward the
site of injury much the same way a spider will migrate toward a
disturbance in the web.
Our study extends the findings of previous investigations by
defining the stages of microglial transformation morphologically
from stages 1A to 6A and back from 6R to 1R, with clear
definitions based on process numbers, size of processes, orientation
and soma size ranges. We have laid out a classification system to
standardize the microglia activation levels. This will also allow for
staging of inflammation based on cell morphology and activation
level. It could give us clues as to how to test for previous exposure
to pathogens. Depending on the reaction from a biopsy we may be
able to use this for a new morphological biomarker for early
detection or even disease progression. Due to the change in
morphology it shows that the cell is reacting differentially to
different types of attack. This could be due to bacterial invasion,
simple inflammation or even the start of cancer. By assessing the
activation stage of the microglia, it might be possible to determine
the extent of the infection or another underlying disease process
noninvasively, looking through the lens of the eye.
In order to determine if this was a robust classification scheme it
was given to two colleagues experienced in cytology and histology.
We asked them to evaluate images from random sections, without
previous training. The two naı¨ve observers came up with a result
that varied from each other less than 2% for each stage, except for
the transition from 6A to 6R, where the variance was 8% between
the subjects. Since there are specific measurements for Stage 1A,
there should be no problem in reproducing the results. All of the
other stages were based on the numbers of stage 1A. For example,
in stage 5A the diameter of the cell was enlarged to 5 times the cell
size of stage 1A. The processes were also evaluated and measured.
We have continued to use this classification system examining
different tissues and it appears to be robust for the examination of
ocular tissue and other parts of the brain.
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